RESELUTE, INC.

DURHAM, NC · Founded 2021 · Medtech · Private

Intramedullary nail implant with integrated sustained-release antibiotic coating for hindfoot fusion and infection prevention

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
DURHAM, NC
Founded
2021
Latest Form D
$1.4M, Jun 2025
Total capital
$5.4M
Federal grants
$1.3M
2 awards · 2024–2025
Rank in peer group#363 of 477
Private capital raised
$4.1M
3 Form D · last Jun 2025
16 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

202320242025FEDERAL ↑EQUITY ↓Cumulative $5.4M$999K$314K1st Form D$700K2nd Form D$2M3rd Form D$1.4M
202320242025FEDERAL ↑EQUITY ↓Cumulative $5.4M$999K$314K1st Form D$700K2nd Form D$2M

Latest events

  • Federal grantHealth and Human S · Phase II · Local and Sustained Release of Antibiotics in the Surgical Treatment of Diabetic Charcot Foot$314K
  • Private capital raisedForm D · SEC · 3rd filing$1.4M
  • Federal grantNSF · Phase II · STTR Phase II: Development of a Antibiotic Releasing Intramedullary Nail for Treatment of Fracture Related Infections$999K
  • Private capital raisedForm D · SEC · 2nd filing$2M
  • Private capital raisedForm D · SEC · 1st filing$700K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Cambre KellyResearcherDirector, Executive OfficerLinked by $999K in grants as PI
  • Andrew BeaverDirectorNamed in SEC Form D filings
  • Ken GallDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingFluted And Fenestrated Intramedullary DevicesUSPTOApplication 19042261
  • PendingFluted And Fenestrated Intramedullary DevicesUSPTOApplication PCTUS2025013972
  • PendingFluted And Fenestrated Intramedullary DevicesUSPTOApplication 63549423

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .